← Eichor
Condition: Graft Rejection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Graft Rejection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Phase 2 · 7 location(s) · Singulera Therapeutics Inc. · NCT06552169Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection
Phase 2 · 1 location(s) · University of Virginia · NCT07046910LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
Phase 2 · 1 location(s) · Steven Hays, MD · NCT06018766Evaluation of the Efficacy of Dd-cfDNA in Routine Patient Care in Kidney Transplant Recipients"
NA · 6 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06406179Detection of Circulating Kidney DNA in Kidney Transplant Patients Facing an Episode of Graft Rejection
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06351488Added Value of 18 FDG Pet-scanner in Diagnosis and Management of Subclinical Rejection in Kidney Transplant Patients
NA · 1 location(s) · University of Liege · NCT04702022Phase I Trial on the Safety of Delayed Infusion of a Naïve T Cell-Depleted Hematopoietic Graft With Memory T Cells in So
Phase 1 · 1 location(s) · Francisco Hernández Oliveros · NCT06997471Impact of the Microbiota on the Likelihood of Renal Graft Rejection
Phase N/A · 9 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04736381Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients
Phase N/A · 1 location(s) · Northwestern University · NCT01531257Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients
EARLY_Phase 1 · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07244419TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients
Phase 3 · 8 location(s) · Vastra Gotaland Region · NCT04561986TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients
Phase 3 · 25 location(s) · University of Sydney · NCT06474273Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated
NA · 1 location(s) · Hospices Civils de Lyon · NCT03955172Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
Phase N/A · 1 location(s) · Liverpool University Hospitals NHS Foundation Trust · NCT06025240Treatment of Antibody-Mediated Rejection (ABMR) With CarBel
Phase 1 · 10 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06918990Non-invasive Detection of Acute Cell-mediated Graft Rejection in Pediatric Heart Transplant Recipients
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06795958Tissue Analysis of Liver Grafts as a Predictor of Transplant Outcome.
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06717542Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
Phase N/A · 19 location(s) · Duke University · NCT06399302Allograft Dysfunction in Heart Transplant
Phase 4 · 1 location(s) · Paul Kim · NCT03102125Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies
Phase 3 · 1 location(s) · University Hospital, Tours · NCT05385432Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab
NA · 1 location(s) · Shahid Beheshti University of Medical Sciences · NCT07006532Daratumumab for Late Antibody-Mediated Rejection
NA · 1 location(s) · University Hospital, Martin · NCT07081126OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
Phase N/A · 7 location(s) · Inova Health Care Services · NCT06939751Cryoprobe Biopsy and Chronic Rejection in Lung Transplant Recipients
NA · 1 location(s) · Mayo Clinic · NCT06824402Prospective Study of White Blood Cells
Phase N/A · 1 location(s) · Quell Therapeutics Limited · NCT04838171A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfun
Phase 3 · 79 location(s) · Sanofi · NCT06082037Trifecta-Kidney cfDNA-MMDx Study
Phase N/A · 31 location(s) · University of Alberta · NCT04239703[68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation
Phase 2 · 1 location(s) · John O. Prior · NCT05499637MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy
NA · 1 location(s) · Centre Hospitalier Universitaire de Besancon · NCT05333367A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantati
Phase 2/Phase 3 · 26 location(s) · Sanofi · NCT07412470
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.